These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 12584084)

  • 1. Factor structure of MicroCog in a clinical sample.
    Lopez SJ; Sumerall SW; Ryan JJ
    Appl Neuropsychol; 2002; 9(3):183-6. PubMed ID: 12584084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Note on comparability of MicroCog test forms.
    Lopez SJ; Edwards LM; Floyd RK; Magyar-Moe J; Rehfeldt JD; Ryder JA
    Percept Mot Skills; 2001 Dec; 93(3):825-8. PubMed ID: 11806607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic variables and microCog performance: relationships for VA patients under treatment for substance abuse.
    Lopez SJ; Ryan JJ; Sumerall SW; Lichtenberg JW; Glasnapp D; Krieshok TS; Van Fleet JN
    Psychol Rep; 2001 Feb; 88(1):183-8. PubMed ID: 11293027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construct validity of the Babcock Story Recall Test.
    Horner MD; Teichner G; Kortte KB; Harvey RT
    Appl Neuropsychol; 2002; 9(2):114-6. PubMed ID: 12214822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot testing of the computerized cognitive test Microcog in chemotherapy-treated older cancer patients.
    Extermann M; Chen H; Booth-Jones M; Meyer J; Balducci L; Jacobsen P
    Crit Rev Oncol Hematol; 2005 May; 54(2):137-43. PubMed ID: 15843096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing cognition following petrol sniffing for Indigenous Australians.
    Dingwall KM; Lewis MS; Maruff P; Cairney S
    Aust N Z J Psychiatry; 2010 Jul; 44(7):631-9. PubMed ID: 20560850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do physicians referred for competency evaluations have underlying cognitive problems?
    Korinek LL; Thompson LL; McRae C; Korinek E
    Acad Med; 2009 Aug; 84(8):1015-21. PubMed ID: 19638765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparability of neuropsychological test profiles in patients with chronic substance abuse and mild traumatic brain injury.
    Lange RT; Iverson GL; Franzen MD
    Clin Neuropsychol; 2008 Mar; 22(2):209-27. PubMed ID: 17853134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derived trail making test cutoffs and malingering among substance abusers.
    Horton AM; Roberts C
    Int J Neurosci; 2005 Jul; 115(7):1083-96. PubMed ID: 16051551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?
    Fernández-Serrano MJ; Pérez-García M; Verdejo-García A
    Neurosci Biobehav Rev; 2011 Jan; 35(3):377-406. PubMed ID: 20451551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the repeatable battery for the assessment of neuropsychological status factor structure appropriate for inpatient psychiatry? An exploratory and higher-order analysis.
    King LC; Bailie JM; Kinney DI; Nitch SR
    Arch Clin Neuropsychol; 2012 Nov; 27(7):756-65. PubMed ID: 22773323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between measures of inhibitory processes in patients with schizophrenia: role of substance abuse disorders.
    Jurado-Barba R; Morales-Muñoz I; Del Manzano BÁ; Fernández-Guinea S; Caballero M; Martínez-Gras I; Rubio-Valladolid G
    Psychiatry Res; 2011 Dec; 190(2-3):187-92. PubMed ID: 21704386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module.
    Grohman K; Fals-Stewart W
    Exp Clin Psychopharmacol; 2004 Aug; 12(3):200-7. PubMed ID: 15301637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of statistical change criteria used to define significant change in neuropsychological test performance following cardiac surgery.
    Raymond PD; Hinton-Bayre AD; Radel M; Ray MJ; Marsh NA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):82-8. PubMed ID: 16337395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid computerized assessment of neurocognitive deficits in bipolar disorder.
    Iverson GL; Brooks BL; Young AH
    Appl Neuropsychol; 2009 Jul; 16(3):207-13. PubMed ID: 20183173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological test performance of Hawai'i high school athletes: Hawai'i ImPACT normative data.
    Tsushima WT; Oshiro R; Zimbra D
    Hawaii Med J; 2008 Apr; 67(4):93-5. PubMed ID: 18524142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive functioning in substance abuse and dependence: a population-based study of young adults.
    Latvala A; Castaneda AE; Perälä J; Saarni SI; Aalto-Setälä T; Lönnqvist J; Kaprio J; Suvisaari J; Tuulio-Henriksson A
    Addiction; 2009 Sep; 104(9):1558-68. PubMed ID: 19686526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor analysis of computerized and traditional tests used in mild brain injury research.
    Bleiberg J; Kane RL; Reeves DL; Garmoe WS; Halpern E
    Clin Neuropsychol; 2000 Aug; 14(3):287-94. PubMed ID: 11262703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.